Company intelligence / Profile preview

Minaris Advanced Therapies

Philadelphia, Pennsylvania, United States

Ownership: Private
Employees: ~1400
Development stage: Other

Overview

Minaris Advanced Therapies supports hundreds of global biopharma innovators with end-to-end manufacturing and testing of cell and gene therapies, leveraging over 25 years' expertise and producing 7,500+ GMP batches, currently manufacturing two commercial therapies

Therapeutic areas: Other
Modalities: Cell therapyGene therapyMonoclonal antibodyViral vectorVaccine
Industry: Contract Manufacturing Organization

Partnerships

Not specifically enumerated; partners with hundreds of global biotech and pharma clients as a CTDMO

Beyond the preview

Go deeper on Minaris Advanced Therapies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Minaris Advanced Therapies.

Explore the full profile